Literature DB >> 25725931

Neurobiological studies on the relationship between toxoplasmosis and neuropsychiatric diseases.

Silvia Fabiani1, Barbara Pinto1, Ugo Bonuccelli2, Fabrizio Bruschi3.   

Abstract

Toxoplasma gondii is a widespread protozoan parasite infecting approximately one third of the world population. After proliferation of tachyzoites during the acute stage, the parasite forms tissue cysts in various anatomical sites including the Central Nervous tissue, and establishes a chronic infection. Clinical spectrum normally ranges from a completely asymptomatic infection to severe multi-organ involvement. Many studies have suggested T. gondii infection as a risk factor for the development of some neuropsychiatric disorders, particularly schizophrenia. During the last years, a potential link with other neurobiological diseases such as Parkinson disease and Alzheimer disease has also been suggested. This review will focus on neurobiological and epidemiological data relating infection with T. gondii to neuropsychiatric diseases.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune response; Neurobiology; Neurological diseases; Neurotransmitter pathway; Schizophrenia spectrum disorders; T. gondii

Mesh:

Year:  2015        PMID: 25725931     DOI: 10.1016/j.jns.2015.02.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  25 in total

Review 1.  The known and missing links between Toxoplasma gondii and schizophrenia.

Authors:  Hany M Elsheikha; Dietrich Büsselberg; Xing-Quan Zhu
Journal:  Metab Brain Dis       Date:  2016-04-04       Impact factor: 3.584

2.  Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia.

Authors:  Jakub Tomasik; Tracey L Schultz; Wolfgang Kluge; Robert H Yolken; Sabine Bahn; Vern B Carruthers
Journal:  Schizophr Bull       Date:  2015-09-20       Impact factor: 9.306

3.  Membrane skeletal association and post-translational allosteric regulation of Toxoplasma gondii GAPDH1.

Authors:  Rashmi Dubey; Bart L Staker; Ian T Foe; Matthew Bogyo; Peter J Myler; Huân M Ngô; Marc-Jan Gubbels
Journal:  Mol Microbiol       Date:  2016-12-23       Impact factor: 3.501

4.  Relationship between Toxoplasma gondii seropositivity and acoustic startle response in an inner-city population.

Authors:  Nick M Massa; Erica Duncan; Tanja Jovanovic; Kimberly Kerley; Lei Weng; Lauren Gensler; Samuel S Lee; Seth Norrholm; Abigail Powers; Lynn M Almli; Charles F Gillespie; Kerry Ressler; Bradley D Pearce
Journal:  Brain Behav Immun       Date:  2016-11-21       Impact factor: 7.217

5.  Chronic Toxoplasma gondii Infection Potentiates Parkinson's Disease Course in Mice Model.

Authors:  Nima Firouzeh; Naser Ziaali; Vahid Sheibani; Amir Hossein Doustimotlagh; Ali Afgar; Maryam Zamanpour; Hossein Keshavarz; Saeideh Shojaee; Reza Shafiei; Khadijeh Esmaeilpour; Zahra Babaei
Journal:  Iran J Parasitol       Date:  2021 Oct-Dec       Impact factor: 1.012

Review 6.  Investigating the Determinants of Toxoplasma gondii Prevalence in Meat: A Systematic Review and Meta-Regression.

Authors:  Simone Belluco; Marzia Mancin; Daniele Conficoni; Giulia Simonato; Mario Pietrobelli; Antonia Ricci
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

Review 7.  Major Developments in the Design of Inhibitors along the Kynurenine Pathway.

Authors:  Kelly R Jacobs; Gloria Castellano-Gonzalez; Gilles J Guillemin; David B Lovejoy
Journal:  Curr Med Chem       Date:  2017       Impact factor: 4.530

8.  Toxoplasma gondii exposure and Parkinson's disease: a case-control study.

Authors:  Cosme Alvarado-Esquivel; Edna Madai Méndez-Hernández; José Manuel Salas-Pacheco; Luis Ángel Ruano-Calderón; Jesús Hernández-Tinoco; Oscar Arias-Carrión; Luis Francisco Sánchez-Anguiano; Francisco Xavier Castellanos-Juárez; Ada Agustina Sandoval-Carrillo; Oliver Liesenfeld; Agar Ramos-Nevárez
Journal:  BMJ Open       Date:  2017-02-13       Impact factor: 2.692

Review 9.  Toxoplasma gondii: A possible etiologic agent for Alzheimer's disease.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Mehdi Sharif; Ahmad Daryani
Journal:  Heliyon       Date:  2021-06-03

10.  Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.

Authors:  Huân M Ngô; Ying Zhou; Hernan Lorenzi; Kai Wang; Taek-Kyun Kim; Yong Zhou; Kamal El Bissati; Ernest Mui; Laura Fraczek; Seesandra V Rajagopala; Craig W Roberts; Fiona L Henriquez; Alexandre Montpetit; Jenefer M Blackwell; Sarra E Jamieson; Kelsey Wheeler; Ian J Begeman; Carlos Naranjo-Galvis; Ney Alliey-Rodriguez; Roderick G Davis; Liliana Soroceanu; Charles Cobbs; Dennis A Steindler; Kenneth Boyer; A Gwendolyn Noble; Charles N Swisher; Peter T Heydemann; Peter Rabiah; Shawn Withers; Patricia Soteropoulos; Leroy Hood; Rima McLeod
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.